Pazopanib in the treatment of advanced renal cell carcinoma
Pazopanib is an oral multitargeted tyrozine kinase inhibitor that is used in advanced renal cancer in most countries of the world. Pazopanib inhibits tyrosine kinase receptors involved in tumor angiogenesis and proliferation, including VEGF, platelet-derived growth factor (PDGF) and stem cell growth...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Remedium Group LLC
2018-11-01
|
| Series: | Медицинский совет |
| Assuntos: | |
| Acceso en liña: | https://www.med-sovet.pro/jour/article/view/2753 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|